Calamos Advisors’s Pediatrix Medical MD Stock Holding History

Calamos Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,500	Closed	-$226K	–	638
2016 Q1	$226K	Hold	3,500	–	–	﹤0.01%	605
2015 Q4	$251K	Hold	3,500	–	–	﹤0.01%	618
2015 Q3	$269K	Sell	3,500 -805	-19%	-$65K	﹤0.01%	634
2015 Q2	$319K	Buy	4,305 +380	+10%	+$27.4K	﹤0.01%	620
2015 Q1	$285K	Buy	+3,925	New	+$273K	﹤0.01%	636
2014 Q4	–	Sell	-9,125	Closed	-$500K	–	671
2014 Q3	$500K	Buy	9,125 +425	+5%	+$24.1K	﹤0.01%	590
2014 Q2	$506K	Hold	8,700	–	–	﹤0.01%	601
2014 Q1	$539K	Sell	8,700 -4,500	-34%	-$262K	﹤0.01%	582
2013 Q4	$705K	Buy	13,200 +2,400	+22%	+$129K	﹤0.01%	554
2013 Q3	$542K	Sell	10,800 -2,800	-21%	-$137K	﹤0.01%	545
2013 Q2	$623K	Buy	+13,600	New	+$609K	﹤0.01%	506

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Calamos Advisors's MD Position: Q2 2016 in Review

Calamos Advisors sold out of Pediatrix Medical (MD) in Q2 2016, closing a stake of 3,500 shares — an estimated $226K sold.

Calamos Advisors first reported a position in MD in Q2 2013 and held it in 11 quarters. The position peaked at $705K in Q4 2013. 391 funds tracked by Wall St. Rank hold MD as of Q2 2016.

Calamos Advisors reported no remaining Pediatrix Medical position as of Q2 2016 after selling out during the quarter.
Calamos Advisors sold 3,500 Pediatrix Medical shares in Q2 2016, an estimated $226K.
Calamos Advisors first reported a position in Pediatrix Medical in Q2 2013 and held it in 11 quarters.
Calamos Advisors's Pediatrix Medical position peaked at $705K in Q4 2013.
391 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2016.

Based on Calamos Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.